Flu transmission study in healthy adults
Part of Infections, Lungs & breathing clinical trials.
This study looks at how the flu spreads from one person to another. Healthy volunteers will be exposed to flu from natural donors while staying in a facility, so researchers can learn more about transmission and help prevent future outbreaks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult aged 18 to 49.
- You must be willing to stay in a quarantine facility for about 2 weeks and follow strict infection-control rules.
- You cannot have received the flu vaccine this season and must not have had the flu recently.
- You must avoid contact with high-risk people (young children, elderly, pregnant women, or those with chronic conditions) for at least 2 weeks after quarantine.
- You must avoid certain medicines (like cold and flu drugs, aspirin, and nasal steroids) for 2 weeks before and during the study.
- You must not live with or have daily contact with infants, children under 5, seniors over 65, or people with weakened immune systems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how healthy adults respond to being exposed to a flu virus in a controlled setting. You will be closely monitored and may help researchers learn more about flu and potential treatments.
This Phase 1 study tests an investigational influenza (flu) approach in a carefully selected group of healthy adults. It may help researchers understand how the flu challenge works and how well the treatment performs and is tolerated.
This study looks at how your immune system (your body’s infection-fighting system) responds during and around the time of a flu illness. It’s meant to help researchers better understand immune changes in healthy adults and may guide future flu care.
This trial tests how the body reacts to a specific flu virus (pH1N1) in a controlled setting. Healthy volunteers are exposed to the virus to help researchers understand the infection and test treatments. You will be monitored closely and given antiviral medication if needed.
This study looks at how your lungs and lymph nodes respond to flu infection and the nasal flu vaccine. It will help researchers understand how to create better protection against the flu.
This study tests a new flu vaccine to see how well it helps the body fight off the flu. It is for generally healthy adults aged 18 to 59 who have not had the flu recently.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.